Evidence map›Paper›PMID 27866964›Full record

ArticleAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2017

Dialysate Potassium, Serum Potassium, Mortality, and Arrhythmia Events in Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Angelo Karaboyas, Jarcy Zee, Steven M Brunelli, Len A Usvyat, Daniel E Weiner, Franklin W Maddux, Allen R Nissenson, Michel Jadoul, Francesco Locatelli, Wolfgang C Winkelmayer and 3 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed, 4 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed, 4 syntheses or guidelines pooled it, 180 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 3 countries.

Angelo KaraboyasArbor Research Collaborative for Health, Ann Arbor, MI. Electronic address: angelo.karaboyas@arborresearch.org.
Jarcy ZeeArbor Research Collaborative for Health, Ann Arbor, MI.
Steven M BrunelliDaVita Clinical Research, Minneapolis, MN.
Len A UsvyatFresenius Medical Care North America, Waltham, MA.
Daniel E WeinerTufts Medical Center, Boston, MA.
Franklin W MadduxFresenius Medical Care North America, Waltham, MA.
Allen R NissensonDaVita Healthcare Partners, Inc, El Segundo, CA; David Geffen School of Medicine at UCLA, Los Angeles, CA.
Michel JadoulCliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Francesco LocatelliAlessandro Manzoni Hospital, Lecco, Italy.
Wolfgang C WinkelmayerBaylor College of Medicine, Houston, TX.
Friedrich K PortArbor Research Collaborative for Health, Ann Arbor, MI; University of Michigan, Ann Arbor, MI.
Bruce M RobinsonArbor Research Collaborative for Health, Ann Arbor, MI; University of Michigan, Ann Arbor, MI.
Francesca TentoriArbor Research Collaborative for Health, Ann Arbor, MI; Vanderbilt University, Nashville, TN.
Arbor Research Collaborative for Health · USFresenius Medical Care (United States) · USUniversity of Michigan–Ann Arbor · USAlessandro Manzoni Hospital · ITBaylor College of Medicine · USDaVita Clinical Research (United States) · USTufts Medical Center · USUCLouvain · BEUniversity of California, Los Angeles · USVanderbilt University · US

Funding

Quality Dialysis Outcomes & Practice Patterns Study (DOPPS) in hemodialysisK01DK087762 · NIDDK · ARBOR RESEARCH COLLABORATIVE FOR HEALTH · PI TENTORI, FRANCESCA · 2011 to 2015
$744k
NIDDK NIH HHS K01 DK087762
6 · The paper itself

Abstract

backgroundSudden death is a leading cause of death in patients on maintenance hemodialysis therapy. During hemodialysis sessions, the gradient between serum and dialysate levels results in rapid electrolyte shifts, which may contribute to arrhythmias and sudden death. Controversies exist about the optimal electrolyte concentration in the dialysate; specifically, it is unclear whether patient outcomes differ among those treated with a dialysate potassium concentration of 3 mEq/L compared to 2 mEq/L. STUDY

designProspective cohort study. SETTING &

participants55,183 patients from 20 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS) phases 1 to 5 (1996-2015). PREDICTOR: Dialysate potassium concentration at study entry. OUTCOMES: Cox regression was used to estimate the association between dialysate potassium concentration and both all-cause mortality and an arrhythmia composite outcome (arrhythmia-related hospitalization or sudden death), adjusting for potential confounders.

resultsDuring a median follow-up of 16.5 months, 24% of patients died and 7% had an arrhythmia composite outcome. No meaningful difference in clinical outcomes was observed for patients treated with a dialysate potassium concentration of 3 versus 2 mEq/L (adjusted HRs were 0.96 [95% CI, 0.91-1.01] for mortality and 0.98 [95% CI, 0.88-1.08] for arrhythmia composite). Results were similar across predialysis serum potassium levels. As in prior studies, higher serum potassium level was associated with adverse outcomes. However, dialysate potassium concentration had only minimal impact on serum potassium level measured predialysis (+0.09 [95% CI, 0.05-0.14] mEq/L serum potassium per 1 mEq/L greater dialysate potassium concentration). LIMITATIONS: Data were not available for delivered (vs prescribed) dialysate potassium concentration and postdialysis serum potassium level; possible unmeasured confounding.

conclusionsIn combination, these results suggest that approaches other than altering dialysate potassium concentration (eg, education on dietary potassium sources and prescription of potassium-binding medications) may merit further attention to reduce risks associated with high serum potassium levels.

Indexed as

Renal DialysisArrhythmias, CardiacFemaleHemodialysis SolutionsHumansKidney Failure, ChronicMaleMiddle AgedOutcome Assessment, Health CarePotassiumProspective StudiesRisk AssessmentHemodialysis SolutionsPotassiumarrhythmiacardiac instabilityDialysate potassiumDialysis Outcomes and Practice Patterns Study (DOPPS)electrolyte shiftend-stage renal disease (ESRD)hemodialysishyperkalemiamortalitypotassium gradientserum potassiumsudden death

Identifiers

PMID27866964
PMCPMC5520979
OpenAlexW2551572216

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.